All Stories

  1. Overlap Syndromes in Autoimmune Connective Tissue Diseases
  2. Lues maligna and HIV mimicking aggressive epidermotropic CD8+ cutaneous T-cell lymphoma
  3. COVID ‐19 vaccine‐related eruption of papules and plaques—A case report
  4. Cutaneous manifestations of aortoiliac occlusive disease: two cases and review of the literature
  5. Cutaneous Manifestations and Their Corresponding Dermoscopic Features in Patients with Dermatomyositis
  6. Reticulated atrophic skin lesions in an adult patient with dermatomyositis and antinuclear matrix protein-2 autoantibodies
  7. Histology of Skin Alterations in Lupus Erythematosus
  8. Atopic Dermatitis: From Etiology and History to Treatment
  9. Herpes Simplex Associated Erythema Multiforme: A Case Report and Review of the Literature
  10. The role of IL-17 rs2275913, IL-17RC rs708567 and TGFB1 rs1800469 SNPs and IL-17A serum levels in patients with lupus nephritis
  11. Ultraviolet diagnostic and treatment modalities in the coronavirus disease 2019 pandemic
  12. CD3Z polymorphisms and promoter hypermethylation in dermatomyositis - the role of cytosine-phosphate-guanine-related single nucleotide polymorphisms
  13. Autoimmune connective tissue diseases in the COVID-19 pandemic
  14. Graham-Little-Piccardi-Lassueur Syndrome: Two Case Reports and Review of the Literature
  15. A boy with linear hyperpigmented atrophic plaques
  16. Lupus erythematosus tumidus in an adolescent with beta thalassemia minor successfully controlled with hydroxychloroquine
  17. Recurrent MVD mutation in European patients with disseminated porokeratosis
  18. Klippel-Trenaunay Syndrome Involving Upper Limb and Chest Wall: A Case Report and Review of the Literature
  19. Neurofibromatosis Type I (Von Recklinghausen Disease): A Case Report and Review of the Literature
  20. Pseudo‐ainhum in a patient with CREST syndrome
  21. Correlation of Disease Activity and Quality of Life of Patients with Psoriasis after Narrow-band Ultraviolet B Therapy
  22. Developing classification criteria for skin‐predominant dermatomyositis: the Delphi process
  23. XRCC1 variants do not represent a risk for dermatomyositis and systemic lupus erythematosus in Bulgarian patients
  24. Genetically Determined TNF-α Secretion Influences the Development of Dermatomyositis and Systemic Lupus Erythematosus
  25. Intravenous immunoglobulins for treatment of connective tissue diseases in dermatology
  26. 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria—methodological aspects
  27. Danko Katalin
  28. Inflammatory Myopathies with Cutaneous Involvement
  29. Association of vitamin D receptor geneBsmI B/b andFokI F/f polymorphisms with adult dermatomyositis and systemic lupus erythematosus
  30. Intravenous Immunoglobulins: Mode of Action and Indications in Autoimmune and Inflammatory Dermatoses
  31. Monoclonal Antibody treatment for SLE
  32. Complications of injected vitamin E as a filler for lip augmentation: case series and therapeutic approach
  33. Oil-Soluble Vitamins: Illegal Use for Lip Augmentation
  34. Association between estrogen receptor-α gene polymorphisms and dermatomyositis in Bulgarian patients
  35. IL-1RN SNP in SLE and DM patients
  36. MBL secreting SNPs in SLE and DM patients
  37. Nevus Comedonicus: An Updated Review
  38. Role of the Promoter Polymorphism IL-6 −174G/C in Dermatomyositis and Systemic Lupus Erythematosus
  39. Perforating Disseminated Necrobiosis Lipoidica Diabeticorum
  40. Clinical variants, stages, and management of basal cell carcinoma
  41. TNF-Alpha SNPs in SLE and DM patients
  42. Sarcoidosis and molecular mimicry—important etiopathogenetic aspects: current state and future directions
  43. Abstracts from EIR School ES01-ES25
  44. IL-10 Single Nucleotide Polymorphisms and Lupus-Nephritis
  45. The Coexistence of Systemic Lupus Erythematosus and Thyrotoxicosis: The Diagnostic Value of Antihistone Antibodies
  46. Quantitative Structure-Activity Relationship Modeling of Dermatomyositis Activity of Drug Chemicals
  47. Dresdner Dermatologische Demonstration 2009 – zugleich Tagung der Sächsischen Dermatologischen Gesellschaft am 7. März 2009
  48. Dermatomyositis
  49. Paraneoplastic dermatological manifestation of gastrointestinal malignancies
  50. Activity of certain drugs in inducing of inflammatory myopathies with cutaneous manifestations
  51. Assen Dourmishev, MD, PhD, DSc, FAAD (1938-2006): Leader of Bulgarian dermatology
  52. Ivermectin: pharmacology and application in dermatology
  53. Segmental ulcerative vasculitis: a cutaneous manifestation of Takayasu's arteritis
  54. Syphilis: Uncommon presentations in adults
  55. Dermatomyositis: comparative studies of cutaneous photosensitivity in lupus erythematosus and normal subjects
  56. Molecular Genetics of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Epidemiology and Pathogenesis
  57. Dermatomyositis: cutaneous manifestations of its variants
  58. D-Penicillamine induced polymyositis and morphea in a woman with Hashimoto thyroiditis
  59. Waardenburg syndrome
  60. Dermatomyositis and Drugs
  61. Dermatomyositis Associated with Malignancy
  62. Efficacy and tolerance of oral ivermectin in scabies
  63. Efficacy and tolerance of oral ivermectin in scabies
  64. Oral ivermectin in scabies patients
  65. Crusted scabies of the scalp in dermatomyositis patients: three cases treated with oral ivermectin
  66. P169 Oral treatment of scabies
  67. Basal and Squamous Cell Carcinoma: Sex, Age and Location Distribution
  68. Basal and squamous cell carcinoma
  69. Dermatomyositis: a retrospective study of 34 inpatients